Breast Cancer Clinical Trials in Las Vegas, NV

Breast Cancer Clinical Trials in Las Vegas, NV

View the best 10 breast cancer medical studies in Las Vegas, Nevada. Access promising new therapies by applying to a Las Vegas-based Breast Cancer clinical trial.

Top rated breast cancer clinical trials in Las Vegas, Nevada

Here are the top 10 medical studies for breast cancer in Las Vegas, Nevada

Michael Bask Gill, B Sc preview

Michael Bask Gill, B Sc

Last Reviewed: April 12th, 2024

Image of Alaska Oncology and Hematology in Anchorage, United States.

Pembrolizumab +1 More

Monoclonal Antibodies

Recruiting4 awardsPhase 3
This trial is testing a new cancer drug against a standard cancer drug, to see if the new drug helps people with a certain type of breast cancer live longer without the cancer getting worse.
Image of UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, United States.

9-ING-41

GSK-3β inhibitor

Recruiting1 awardPhase 2
This trial is testing a new drug to see if it is safe and effective in treating cancer. The drug is designed to target a protein called GSK-3β, which is found in many different types of cancer cells.
Image of University of Alabama at Birmingham in Birmingham, United States.

Abemaciclib

CDK4/6 Inhibitor

Recruiting1 awardPhase 3
This trial is testing abemaciclib as a treatment for early breast cancer in people who are also taking hormone therapy. It will last up to 10 years.
Image of Nevada Cancer Institute in Las Vegas, United States.

Exercise Regimen

Behavioural Intervention

Recruiting1 award6 criteria
This trial will compare the outcomes of two groups, one of which will receive a physical activity intervention while the other will only receive limited information on activity.
Image of University of California, San Francisco in San Francisco, United States.

Atorvastatin +1 More

HMG-CoA reductase inhibitor

Recruiting2 awardsPhase 2
This trial is testing whether the cholesterol-lowering medication atorvastatin can reduce the risk of breast cancer.
Image of Carle Cancer Center in Urbana, United States.

Denosumab

Monoclonal Antibodies

Recruiting1 awardPhase 3
This trial is testing whether denosumab can prevent breast cancer in women with a BRCA1 gene mutation, which is linked to a higher risk of developing the disease.
Image of HonorHealth Research Institute - Bisgrove in Scottsdale, United States.

Autogene Cevumeran +1 More

Cancer Vaccine

Recruiting1 awardPhase 1
This trial is testing a new drug, RO7198457, to see if it is safe and works well against cancer.
Image of Research Site in Jonesboro, United States.

Durvalumab +2 More

Monoclonal Antibodies

Recruiting2 awardsPhase 3
This trial tests the effectiveness and safety of new treatments for TNBC and hormone receptor-low/HER2-negative breast cancer.
Image of King Regional Medical Center in Kingman, United States.

Chemotherapy

Recruiting1 awardPhase 2
This trial tests if a scan using a radioactive tracer & imaging can help doctors predict how well standard chemotherapy will work in HER2+ breast cancer patients.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Capivasertib +18 More

Kinase Inhibitor

Recruiting1 awardPhase 2
This trial uses genomic testing to direct cancer treatment. Patients with cancer that has progressed after standard treatment or for which there is no agreed-upon treatment may benefit.

Popular filter options for breast-cancer las-vegas trials

Age 65+
Phase 3
< 50 mile distance
No Placebo

Phase 3 Clinical Trials

View 40 phase 3 medical studies.

Anchorage, Alaska

Alkylating agents

Doxorubicin Hydrochloride +2 More for Breast Cancer

Recruiting2 awardsPhase 3
Palm Springs, California
This trial is testing two different chemotherapy combinations to treat triple negative breast cancer to see which is more effective.
Mobile, Alabama

Platinum-based Chemotherapy

Platinum Chemotherapy for Triple-Negative Breast Cancer

Recruiting3 awardsPhase 3
Kingman, Arizona
This trial is comparing two types of chemotherapy drugs to see which is more effective in treating patients with residual triple negative basal-like breast cancer.
Tucson, Arizona

Monoclonal Antibodies

T-DXd +/− Pertuzumab for Breast Cancer

Recruiting1 awardPhase 3
Las Vegas, Nevada
This trial will test a new cancer drug to see if it is effective and safe for patients with HER2-positive breast cancer.
Birmingham, Alabama

CDK4/6 Inhibitor

Abemaciclib + Hormone Therapy for Breast Cancer

Recruiting1 awardPhase 3
Las Vegas, Nevada
This trial is testing abemaciclib as a treatment for early breast cancer in people who are also taking hormone therapy. It will last up to 10 years.
Urbana, Illinois

Monoclonal Antibodies

Denosumab to Prevent Breast Cancer in Women With BRCA1 Mutation

Recruiting1 awardPhase 3
Las Vegas, Nevada
This trial is testing whether denosumab can prevent breast cancer in women with a BRCA1 gene mutation, which is linked to a higher risk of developing the disease.
Birmingham, Alabama

Monoclonal Antibodies

T-DM1 + Tucatinib for Breast Cancer

Recruiting1 awardPhase 3
Kingman, Arizona
This trial tests a combination of two drugs to see if they're better than one drug at preventing breast cancer from coming back in patients with high risk, HER2 positive breast cancer.

Clinical Trials With No Placebo

View 40 medical studies that do not have a placebo group.

San Francisco, California

GSK-3β inhibitor

9-ING-41 for Advanced Cancers

Recruiting1 awardPhase 2
Las Vegas, Nevada
This trial is testing a new drug to see if it is safe and effective in treating cancer. The drug is designed to target a protein called GSK-3β, which is found in many different types of cancer cells.
Scottsdale, Arizona

Cancer Vaccine

Autogene Cevumeran + Atezolizumab for Cancer

Recruiting1 awardPhase 1
Las Vegas, Nevada
This trial is testing a new drug, RO7198457, to see if it is safe and works well against cancer.
Gilbert, Arizona

Tyrosine Kinase Inhibitor

Cabozantinib + Atezolizumab for Advanced Cancers

Recruiting1 awardPhase 1 & 2
Las Vegas, Nevada
This trial is testing the safety and effectiveness of a new cancer drug when used in combination with another cancer drug. The new drug is being tested on people with different types of cancer, including bladder, kidney, prostate, and breast cancer.
Santa Monica, California

Monoclonal Antibodies

Xentuzumab + Abemaciclib for Breast Cancer

Recruiting1 awardPhase 1
Las Vegas, Nevada
This trial is testing the combination of two drugs, xentuzumab and abemaciclib, to see if they are safe and effective at shrinking tumors in patients with lung and breast cancer.
Anchorage, Alaska

Alkylating agents

Doxorubicin Hydrochloride +2 More for Breast Cancer

Recruiting2 awardsPhase 3
Palm Springs, California
This trial is testing two different chemotherapy combinations to treat triple negative breast cancer to see which is more effective.
Birmingham, Alabama

Kinase Inhibitor

Targeted Therapy for Cancer

Recruiting1 awardPhase 2
Kingman, Arizona
This trial uses genomic testing to direct cancer treatment. Patients with cancer that has progressed after standard treatment or for which there is no agreed-upon treatment may benefit.

View More Breast-cancer Las-vegas Trials

See another 23 medical studies focused on breast-cancer las-vegas.

Paclitaxel +1 More

Tucatinib +1 More

Usual care disease monitoring +1 More

Fulvestrant

Pembrolizumab +1 More

Niraparib

Sacituzumab Govitecan-hziy

Trastuzumab Deruxtecan +4 More

Control arm

Giredestrant +1 More

Tamoxifen +3 More

ARX788

Gemcitabine +1 More

Durvalumab +2 More

Durvalumab +3 More

Pembrolizumab

Camizestrant

Chemotherapy

FSRS +1 More

ARV-471

Elacestrant

Hormone Therapy

Sotorasib +8 More

View more breast-cancer clinical trials las-vegas

See more medical studies focusing on breast-cancer las-vegas

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top